PathAI Adds MET Predict to AISight for NSCLC Assessments
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read MorePosted by Andy Lundin | Sep 11, 2024 | Digital Pathology, Lung Cancer |
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read MorePosted by Andy Lundin | Sep 11, 2024 | Cancer |
SOPHiA GENETICS and AstraZeneca will expand the reach of the MSK-ACCESS liquid biopsy test to enhance cancer diagnostics options.
Read MorePosted by Chris Wolski | Sep 10, 2024 | Prostate |
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read MorePosted by Chris Wolski | Aug 29, 2024 | Sexually Transmitted Diseases |
Eurofins has launched the Mplex Mpox, Orthopox real-time PCR assay for the qualitative detection and differentiation of the mpox virus.
Read MorePosted by Andy Lundin | Aug 28, 2024 | Cancer |
The FDA approved Illumina’s oncology comprehensive test as an IVD tool, along with its first two CDx indications for cancer patients.
Read More